Via the pro-inflammatory Toll-like receptor 4 (TLR4) pathway, exposure to active ATIs can lead to intestinal inflammation and deterioration of pre-existing inflammatory diseases such as non-alcoholic fatty liver disease and colitis [13,14,15]. The gene discussed is TLR4; the disease is colitis.